Therefore, encouraging results were published by Choi et al. treating 41 adult patients suffering mainly from leukemia with haploidentical NK cell immunotherapy generated from CD3-depleted primary material stimulated with IL-15, IL-21 and hydrocortisone over a period of 13 to 20 days. This evidence concerns the gene IL21 and leukemia.